Papillomavirus Infections
66
1
9
40
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
16 trials with published results (24%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.1%
4 terminated out of 66 trials
90.9%
+4.4% vs benchmark
30%
20 trials in Phase 3/4
40%
16 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (66)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)
Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)
DNA Methylation and the Increased Risk of Cervical Cancer Development
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
Cantharidin and Occlusion in Verruca Epithelium
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities
ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection
HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme